Sixteen patients under regular hemodialysis were investigated for their serum osteocalcin (OC) BUN, creatinine, and PTH. To evaluate the effect of lα(OH) D
3 on the serum level of OC, the changes of these parameters following lα(OH)D
3 treatment for 10.2 ±;5.5 months (mean ± SD) were investigated. The mean daily dose was 0.53 ± 0.16 μg/day. OC was increased from 24.6 ± 20.4 ng/ml to 49.7 ± 42.6 ng/ml (p<0.05) after the lα(OH)D
3 treatment. The natural course of hemodialysis and/or less efficient dialysis technique were not responsible for the increase in OC because of the insignificant relation between the OC level and duration of dialysis, and insignificant changes in BUN, creatinine, and PTH levels during the treatment. Significant positive correlations were found between the daily VD dose and the increase in OC level (r=0.513, p<0.02), and the serum OC level (r=0.701, p <0.01) after the VD treatment. These data suggest that long-term treatment with lα(OH)D
3 increases the serum OC level in dialyzed patients, possibly due to improvement of the relative vitamin D deficiency in these patients, followed by an increase of OC synthesis.
抄録全体を表示